I obtained my Bachelor's of Science degree in Biological sciences from Northeastern University in 2018, and am on track to recieve a Masters in Biology from the Harvard Extension School in 2023 upon successful completion of my thesis.  I am currently a Research Technician III working in the Lab of Peter Sorger at Harvard Medical School, and am affilated with the Laboratory of Systems Pharmacology (LSP). Before joining the LSP, I was a research assistant at Repligen, Northeastern University's Center for Drug Discovery, and Pfizer Cambridge, where I worked to investigate the roles of intracellular receptors in addiction, Alzheimer's disease, and drug sensitivity. My work in the LSP includes dose response profiling of anti-cancer therapeutics across multiple cell lines as part of the LINCS project, as well as using CRISPR-Cas9 to develop in-vitro model systems to probe cancer biology.  At the onset of the COVID19 pandemic, I put a hold on my usual projects to work with the Springer Lab at Harvard Medical School to develop a new rapid test for the SARS-CoV-2 virus.   Upon returning to business as usual, I began generating CRISPRa and CRISPRi cell lines to characterize the function of membrane transport proteins to identify potential therapeutic targets for metabolic diseases and cancer.  My current work involves developing Cyclic Immunofluorescence (CyCIF), an imaging platform which allows for highly multiplexed immunofluorescent imaging of tissue samples.  I hope to improve the platform in ways which will enhance its diagnostic potential and support new discoveries to uncover how tumor heterogeneity and tumor microenvironment interactions support cancer progression.  I hope to continue producing high quality, reproducible data and develop the experience to take on diverse and complex scientific problems.